Tempus AI (NASDAQ:TEM) Receives Neutral Rating from Piper Sandler

Piper Sandler reaffirmed their neutral rating on shares of Tempus AI (NASDAQ:TEM) in a research report report published on Tuesday morning,Benzinga reports. They currently have a $70.00 target price on the stock, up from their previous target price of $40.00.

A number of other brokerages have also recently issued reports on TEM. Loop Capital raised their target price on Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a report on Tuesday, October 15th. JPMorgan Chase & Co. boosted their price objective on shares of Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Bank of America lowered shares of Tempus AI from a “buy” rating to a “neutral” rating and increased their target price for the stock from $45.00 to $60.00 in a report on Wednesday, October 2nd. Needham & Company LLC reissued a “buy” rating and issued a $47.00 target price on shares of Tempus AI in a research note on Wednesday, August 7th. Finally, Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and raised their price target for the stock from $45.00 to $65.00 in a research report on Monday. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $54.22.

Tempus AI Price Performance

TEM stock opened at $68.04 on Tuesday. Tempus AI has a twelve month low of $22.89 and a twelve month high of $79.49. The company has a debt-to-equity ratio of 8.17, a quick ratio of 3.52 and a current ratio of 2.69. The company has a fifty day moving average of $50.90.

Institutional Trading of Tempus AI

A number of hedge funds and other institutional investors have recently made changes to their positions in TEM. First Horizon Advisors Inc. acquired a new position in Tempus AI during the third quarter worth $30,000. Vestor Capital LLC acquired a new position in shares of Tempus AI during the 3rd quarter worth about $153,000. Sandia Investment Management LP bought a new position in shares of Tempus AI in the 2nd quarter valued at about $136,000. IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new stake in shares of Tempus AI in the third quarter valued at about $258,000. Finally, Clarus Group Inc. acquired a new stake in shares of Tempus AI in the third quarter valued at about $283,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.